Security key
71715X104
PHARMACYTE BIOTECH INC COM NEW - Stock (PMCB)
CUSIP: 71715X104
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Stock
- Total 13F shares
- 2
- Total 13F value
- $1
- Share change
- 0
- SEC-reported price per share
- $0.50
- Number of holders
- 1
Report period
Q4 2025
Institutions
1
Top holders
1
PMCB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
PharmaCyte Biotech, Inc. SEC filings
PharmaCyte Biotech, Inc. company facts
PharmaCyte Biotech, Inc. 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 71715X104
Recent filing periods:
Ownership snapshot
Top reported holders of PMCB - PHARMACYTE BIOTECH INC COM NEW - Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ayrton Capital LLC
Disclosed value leader
Ayrton Capital LLC
Comparable rows
2/15
Latest evidence
31 Dec 2025
13D/G
13F
Lead comparable stake: 9.9%
13 rows are not safely comparable across share classes.
13D/G row: Ayrton Capital LLC
Showing 1-6 of 15 holder rows.
Quick read
Ayrton Capital LLC leads the comparable SEC ownership view at 9.9%.
2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ayrton Capital LLC's linked filing trail.
Comparable ownership
Top 2
Ayrton Capital LLC
9.9%
INTRACOASTAL CAPITAL, LLC
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ayrton Capital LLC |
13D/G
|
9.9%
Reported 13D/G
· 31 Dec 2024
|
$967,625
774,100 shares
|
$0 | 31 Dec 2024 |
| INTRACOASTAL CAPITAL, LLC |
13D/G
Mitchell P. Kopin
|
5%
Reported 13D/G
· 31 Dec 2025
|
$484,351
532,254 shares
|
$0 | 31 Dec 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$122,767
126,603 shares
|
— | 30 Sep 2025 |
| EQUITEC PROPRIETARY MARKETS, LLC |
13F
Company
|
—
denominator unverified
|
$80,212
82,727 shares
|
— | 30 Sep 2025 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
—
denominator unverified
|
$77,568
80,000 shares
|
— | 30 Sep 2025 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$72,671
74,919 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
2
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q4 2025 holders
1
Holder diff
0
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend